$AXON Axovant Gene Therapies Ltd. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Axovant Gene Therapies Ltd..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Axovant Gene Therapies Ltd.. Insider overview, share value development, latest insider transactions and email notifications about new events in Axovant Gene Therapies Ltd. for free.

CIK Number: 0001636050
IRS Number: 981333697
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AXON
Company Address: 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON SW1Y 4LB
Former name: Axovant Sciences, Inc., date of change: 2015-03-24
Former name: Roivant Neurosciences Ltd., date of change: 2015-03-09
Former name: Axovant Sciences Ltd., date of change: 2015-03-24

Market Capitalization: $1.28B
Prev close: $12.97
Average Daily Volume: 286,313
Days Low: $12.83
Year Low: $9.19
Year High: $17.66

Axovant Gene Therapies Ltd. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Cheruvu PavanPrincipal Executive Officer7,50097,275shares bought: 7,500 / shares sold: 0 BUYApr 17 20202 months ago
Corcoran GavinEVP of R&D00Apr 17 20202 months ago
Modig BerndtDirector77,9141,010,545Apr 17 20202 months ago
Nassif David W.Principal Financial Officer00Apr 17 20202 months ago
Pande AtulDirector13,370173,409shares bought: 13,370 / shares sold: 0 STRONG BUYApr 17 20202 months ago
Sundaram Senthil VelDirector00Apr 17 20202 months ago
Torti FrankDirector00Apr 17 20202 months ago

View all Axovant Gene Therapies Ltd. insiders.

Axovant Gene Therapies Ltd. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 17 2020AXONAxovant Gene Thera ...Modig BerndtDirectorOption ExerciseA3.4517,50060,37517,500
Apr 17 2020AXONAxovant Gene Thera ...Pande AtulDirectorOption ExerciseA3.4517,50060,37517,500
Apr 17 2020AXONAxovant Gene Thera ...Torti FrankDirectorOption ExerciseA3.4517,50060,37517,500
Apr 17 2020AXONAxovant Gene Thera ...Sundaram Senthil VelDirectorOption ExerciseA3.4517,50060,37517,500
Apr 17 2020AXONAxovant Gene Thera ...Corcoran GavinEVP of R&DOption ExerciseA0.0042,400042,400
Apr 17 2020AXONAxovant Gene Thera ...Corcoran GavinEVP of R&DOption ExerciseA3.4563,700219,76563,700
Apr 17 2020AXONAxovant Gene Thera ...Nassif David W.Principal Financial ...Option ExerciseA0.0052,600052,600
Apr 17 2020AXONAxovant Gene Thera ...Nassif David W.Principal Financial ...Option ExerciseA3.4578,900272,20578,900
Apr 17 2020AXONAxovant Gene Thera ...Cheruvu PavanPrincipal Executive ...Option ExerciseA0.00112,7000112,700
Apr 17 2020AXONAxovant Gene Thera ...Cheruvu PavanPrincipal Executive ...Option ExerciseA3.45169,100583,395169,100
Mar 18 2020AXONAxovant Gene Thera ...Pande AtulDirectorBuyP1.7810,00017,84413,3703.4 K to 13.4 K (+296.74 %)
Feb 27 2020AXONAxovant Gene Thera ...Roivant Sciences Ltd.10% OwnerBuyP3.755,333,33319,999,99918,577,38013.2 M to 18.6 M (+40.27 %)
Sep 24 2019AXONAxovant Gene Thera ...Corcoran GavinEVP of R&DOption ExerciseA0.0032,003032,003
Sep 24 2019AXONAxovant Gene Thera ...Nassif David W.Principal Financial ...Option ExerciseA0.0030,120030,120
Sep 24 2019AXONAxovant Gene Thera ...Cheruvu PavanPrincipal Executive ...Option ExerciseA0.0045,181045,181

View all Axovant Gene Therapies Ltd. insider transactions.